抓获集群:定义和治疗中的当前概念
Gemma Bassani1, Elena Pasini2, Barbara Mostacci2
1Department of Biomedical and NeuroMotor Sciences (DIBINEM), University of Bologna, 40126 Bologna, Italy.
Journal of clinical medicine
|March 14, 2026
概括
集群 (SCs) 需要及时治疗,但缺乏通用定义,导致管理变化. 有证据表明,门诊鼻喷雾剂和口服溶液的疗效相似,推个性化行动计划.
科学领域:
- 神经学 神经学
- 临床药理学 临床药理学
背景情况:
- 集群 (SCs) 是一个具有增加风险的关键神经事件.
- 不同类型的SCs管理源于未定义的标准和不同的护理环境.
研究的目的:
- 审查和分析集群的治疗方法.
- 在门诊,ED和EMU环境中比较疗效和安全性.
- 为了确定SC管理的差距和建议.
主要方法:
- 对32篇关于SC治疗的原始文章的文献综述.
- 分析的重点是定义,疗效和不良事件.
- 根据临床情景进行分类:门诊,急诊室 (ED) 和监测单元 (EMU).
主要成果:
- 门诊性SC治疗的疗效与隔离剂鼻喷雾,米达佐拉姆鼻喷雾和口服洛拉泽相似,尽管受研究异质性的限制.
- 住院患者的管理与状态的协议保持一致,有利于输入式类药物和随后的抗发作药物.
- 经验性的ED定义 (例如,超过3次发作/24小时) 有助于及时介入.
结论:
- 推针对患者的急性发作行动计划 (ASAP),以个性化的SC定义,用于门诊护理.
- 药物的地理可用性影响治疗标准化.
- 住院和ED管理显示出比门诊更大的共识.
相关概念视频
Seizures: Classification
2.0K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.0K
Epilepsy and Seizures: Overview
1.6K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
Antiepileptic Drugs: Sodium Channel Blockers
2.1K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.1K
Electroconvulsive Therapy
1.7K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.7K
Antiepileptic Drugs: Potassium Channel Activators
895
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
895
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.6K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.6K


